Medical Innovation Holdings Top Insiders
Medical Innovation employs about 9 people. The company is managed by 11 executives with a total tenure of roughly 94 years, averaging almost 8.0 years of service per executive, having 0.82 employees per reported executive. Assessment of Medical Innovation's management performance can provide insight into the firm performance.
| Arturo Sanchez CEO CEO |
| Daniel Medina CEO CEO and President and Director |
Medical |
Medical Innovation Management Team Effectiveness
Medical Innovation's management efficiency ratios could be used to measure how well Medical Innovation manages its routine affairs as well as how well it operates its assets and liabilities.Medical Innovation Workforce Comparison
Medical Innovation Holdings is considered to be number one stock in number of employees category among related companies. The total workforce of Medical Care Facilities industry is now estimated at about 45,291. Medical Innovation adds roughly 9.0 in number of employees claiming only tiny portion of all equities under Medical Care Facilities industry.
Medical Innovation Notable Stakeholders
A Medical Innovation stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medical Innovation often face trade-offs trying to please all of them. Medical Innovation's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medical Innovation's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Arturo Sanchez | CEO | Profile | |
| Daniel Medina | CEO and President and Director | Profile | |
| Raimundo Dias | President Corporate Secretary, Director | Profile | |
| Lawrence Litowitz | Interim CFO | Profile | |
| John Stol | Director | Profile | |
| Redgie Green | Director | Profile | |
| Bart Siegel | Director | Profile | |
| Raymond Demotte | CFO, Director | Profile | |
| Madhava Mankal | CFO and Director | Profile | |
| John Lewis | Director | Profile | |
| Michael Gallo | Director | Profile |
Medical Innovation Workforce Analysis
Traditionally, organizations such as Medical Innovation use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medical Innovation within its industry.Medical Innovation Manpower Efficiency
Return on Medical Innovation Manpower
| Revenue Per Employee | 5.3K | |
| Revenue Per Executive | 4.4K | |
| Net Loss Per Employee | 158.9K | |
| Net Loss Per Executive | 130K |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Medical Innovation information on this page should be used as a complementary analysis to other Medical Innovation's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Medical OTC BB Equity
If you are still planning to invest in Medical Innovation check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medical Innovation's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |